Study
Nanomedicine in 2026: Illustrative Quantitative Analyses of EPR Heterogeneity, Clinical Trial Attrition, and Emerging Horizons for Active Nanotherapeutics
2026 · other · peer reviewed: yes · record 42311422 · PubMed
1 finding kept from this study. Each is one sentence comparing an animal with a human, extracted from the full text, checked against the located page, and adjudicated against the review's definition of an animal-versus-human comparison.
Median nanoparticle tumour-to-blood ratio was 8.5 in murine models versus 1.8 in human tumours from the same publications (23 studies, 412 patients).
Discordant · level C · mouse · oncology · 8.5 ratio
“compared to a median of 8.5 (IQR: 5.1-14.2) in murine models from the same publications.”
page 6
Full texts are copyrighted and are not republished here. The quote is the evidence for the extracted value, and the page number lets you check it in the original.